New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareMOTS-c vs Carnosine

MOTS-c vs Carnosine

Side-by-side comparison of key properties, dosing, and research.

Anti-Aging & Longevity
MOTS-c
Anti-Aging & LongevityRecovery & Repair
Carnosine
Summary
MOTS-c is a mitochondria-derived peptide (MDP) encoded within the mitochondrial genome. It acts as a metabolic regulator, improving insulin sensitivity, enhancing exercise capacity, and counteracting age-related metabolic decline. It is often called a 'mitochondrial hormone.'
Carnosine is an endogenous dipeptide (beta-alanine + histidine) found in high concentrations in muscle and brain. It is a potent anti-aging molecule with broad spectrum antioxidant, anti-glycation, anti-carbonylation, and metal chelating properties, making it one of the most protective naturally occurring dipeptides.
Half-Life
Estimated 1–2 hours
~1.5 minutes (rapidly hydrolyzed to beta-alanine and histidine by carnosinase in blood; tissue levels maintained via constant synthesis)
Admin Route
SubQ
Oral, Topical
Research
Typical Dose
5–15 mg
1,000–2,000 mg
Frequency
3–5 times per week
Once to twice daily with meals
Key Benefits
  • Improves insulin sensitivity and glucose metabolism
  • Enhances exercise capacity and endurance
  • Reduces age-related metabolic decline
  • Activates AMPK — the master metabolic regulator
  • Promotes fat oxidation
  • Anti-inflammatory effects
  • May extend healthspan via mitochondrial optimization
  • Increases energy and reduces fatigue
  • Potent anti-glycation (prevents protein cross-linking/aging)
  • Broad-spectrum antioxidant in muscle and brain
  • Extends cell lifespan and protects telomeres
  • Improves muscle performance and delays fatigue (pH buffering)
  • Neuroprotective against Alzheimer's amyloid-beta
  • Wound healing acceleration
  • Anti-cataract properties (eye health)
  • Improves diabetes complications via AGE prevention
  • Chelates excess copper and zinc
Side Effects
  • Injection site irritation
  • Fatigue during initial adaptation
  • Unknown long-term profile (limited human data)
  • Very well tolerated
  • Rare: mild GI discomfort at high doses
  • No significant adverse effects in human studies
Stacks With